Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D3, and Epstein-Barr virus

Compston, 2002, Multiple sclerosis, Lancet, 359, 1221, 10.1016/S0140-6736(02)08220-X Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, Ann Neurol, 58, 840, 10.1002/ana.20703 Charil, 2007, Inflammatory demyelination and neurodegeneration in early multiple sclerosis, J Neurol Sci, 259, 7, 10.1016/j.jns.2006.08.017 De Stefano, 2001, Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability, Arch Neurol, 58, 65, 10.1001/archneur.58.1.65 Sospedra, 2005, Immunology of multiple sclerosis, Annu Rev Immunol, 23, 683, 10.1146/annurev.immunol.23.021704.115707 Gunnarsson, 2011, Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab, Ann Neurol, 69, 83, 10.1002/ana.22247 Mendes, 2011, Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works, Arq Neuropsiquiatr, 69, 536, 10.1590/S0004-282X2011000400024 Panitch, 2004, Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study, Neurology, 63, 1788, 10.1212/01.WNL.0000146958.77317.3E Hillert, 1993, HLA and MS, Neurology, 43, 2426, 10.1212/WNL.43.11.2426-a Haines, 1998, Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group, Hum Mol Genet, 7, 1229, 10.1093/hmg/7.8.1229 Chiang, 2000, Cbl-b regulates the CD28 dependence of T-cell activation, Nature, 403, 216, 10.1038/35003235 Tuohy, 1999, Regression and spreading of self-recognition during the development of autoimmune demyelinating disease, J Autoimmun, 13, 11, 10.1006/jaut.1999.0293 Willer, 2003, Twin concordance and sibling recurrence rates in multiple sclerosis, Proc Natl Acad Sci U S A, 100, 12877, 10.1073/pnas.1932604100 Burrell, 2011, Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC), Discov Med, 11, 187 Kurtzke, 2001, Multiple sclerosis in the Faroe Islands: an epitome, J Clin Epidemiol, 54, 1, 10.1016/S0895-4356(00)00268-7 Reiber, 1998, The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis, Mult Scler, 4, 111, 10.1177/135245859800400304 Lycke, 1996, Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study, J Neurol, 243, 214, 10.1007/BF00868517 Bech, 2002, A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS, Neurology, 58, 31, 10.1212/WNL.58.1.31 Friedman, 2005, A randomized clinical trial of valacyclovir in multiple sclerosis, Mult Scler, 11, 286, 10.1191/1352458505ms1185oa Wucherpfennig, 1995, Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein, Cell, 80, 695, 10.1016/0092-8674(95)90348-8 Thacker, 2006, Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis, Ann Neurol, 59, 499, 10.1002/ana.20820 Ascherio, 2007, Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors, Ann Neurol, 61, 504, 10.1002/ana.21141 Pohl, 2006, High seroprevalence of Epstein-Barr virus in children with multiple sclerosis, Neurology, 67, 2063, 10.1212/01.wnl.0000247665.94088.8d Ascherio, 2001, Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study, JAMA, 286, 3083, 10.1001/jama.286.24.3083 Sundstrom, 2004, An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study, Neurology, 62, 2277, 10.1212/01.WNL.0000130496.51156.D7 Wandinger, 2000, Association between clinical disease activity and Epstein-Barr virus reactivation in MS, Neurology, 55, 178, 10.1212/WNL.55.2.178 Bray, 1992, Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein, Neurology, 42, 1798, 10.1212/WNL.42.9.1798 Lang, 2002, A functional and structural basis for TCR cross-reactivity in multiple sclerosis, Nat Immunol, 3, 940, 10.1038/ni835 Prat, 2005, HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype, J Neuroimmunol, 167, 108, 10.1016/j.jneuroim.2005.04.027 Perl, 2003, Role of endogenous retroviruses in autoimmune diseases, Rheum Dis Clin North Am, 29, 123, 10.1016/S0889-857X(02)00098-4 Rickinson, 2001, Epstein‐Barr virus, 2575 Pender, 2003, Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases, Trends Immunol, 24, 584, 10.1016/j.it.2003.09.005 Colombo, 2000, Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients, J Immunol, 164, 2782, 10.4049/jimmunol.164.5.2782 Owens, 2003, Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid, J Immunol, 171, 2725, 10.4049/jimmunol.171.5.2725 Serafini, 2007, Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain, J Exp Med, 204, 2899, 10.1084/jem.20071030 horley-Lawson, 2001, Epstein-Barr virus: exploiting the immune system, Nat Rev Immunol, 1, 75, 10.1038/35095584 Kuppers, 2003, B cells under influence: transformation of B cells by Epstein-Barr virus, Nat Rev Immunol, 3, 801, 10.1038/nri1201 Hauser, 2008, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, N Engl J Med, 358, 676, 10.1056/NEJMoa0706383 Dreyfus, 2011, Autoimmune disease: a role for new anti-viral therapies?, Autoimmun Rev, 11, 88, 10.1016/j.autrev.2011.08.005 Kurtzke, 1977, Geography in multiple sclerosis, J Neurol, 215, 1, 10.1007/BF00312546 van der Mei, 2003, Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case–control study, BMJ, 327, 316, 10.1136/bmj.327.7410.316 Islam, 2007, Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins, Neurology, 69, 381, 10.1212/01.wnl.0000268266.50850.48 Yetley, 2008, Assessing the vitamin D status of the US population, Am J Clin Nutr, 88, 558S, 10.1093/ajcn/88.2.558S Holick, 2004, Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease, Am J Clin Nutr, 80, 1678S, 10.1093/ajcn/80.6.1678S Westberg, 2009, Occupational exposure to UV light and mortality from multiple sclerosis, Am J Ind Med, 52, 353, 10.1002/ajim.20682 Willer, 2005, Timing of birth and risk of multiple sclerosis: population based study, BMJ, 330, 120, 10.1136/bmj.38301.686030.63 Soilu-Hanninen, 2008, A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis, J Neurol Neurosurg Psychiatry, 79, 152, 10.1136/jnnp.2006.105320 Ramagopalan, 2009, Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D, PLoS Genet, 5, e1000369, 10.1371/journal.pgen.1000369 Handunnetthi, 2010, Multiple sclerosis, vitamin D, and HLA-DRB1*15, Neurology, 74, 1905, 10.1212/WNL.0b013e3181e24124 Ahn, 2010, Genome-wide association study of circulating vitamin D levels, Hum Mol Genet, 19, 2739, 10.1093/hmg/ddq155 Cantorna, 2004, Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system, Am J Clin Nutr, 80, 1717S, 10.1093/ajcn/80.6.1717S Sabetta, 2010, Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults, PLoS One, 5, e11088, 10.1371/journal.pone.0011088 Roth, 2010, Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh, Acta Paediatr, 99, 389, 10.1111/j.1651-2227.2009.01594.x Grant, 2008, Hypothesis — ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers, Photochem Photobiol, 84, 356, 10.1111/j.1751-1097.2007.00266.x Grant, 2010, Latitude and multiple sclerosis prevalence: vitamin D reduces risk of Epstein-Barr virus infection, Mult Scler, 16, 373, 10.1177/1352458509358093 Pierrot-Deseilligny, 2009, Clinical implications of a possible role of vitamin D in multiple sclerosis, J Neurol, 256, 1468, 10.1007/s00415-009-5139-x Zamboni, 2009, Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis, J Neurol Neurosurg Psychiatry, 80, 392, 10.1136/jnnp.2008.157164 Zamboni, 2006, The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis, J R Soc Med, 99, 589, 10.1258/jrsm.99.11.589 Kilic, 2008, Anatomy of cerebral veins and sinuses, Front Neurol Neurosci, 23, 4, 10.1159/000111256 Zamboni, 2009, Venous collateral circulation of the extracranial cerebrospinal outflow routes, Curr Neurovasc Res, 6, 204, 10.2174/156720209788970054 Law, 2004, Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter, Radiology, 231, 645, 10.1148/radiol.2313030996 Franceschi, 2009, The unsolved puzzle of multiple sclerosis and venous function, J Neurol Neurosurg Psychiatry, 80, 358, 10.1136/jnnp.2008.168179 Zamboni, 2009, The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis, J Neurol Sci, 282, 21, 10.1016/j.jns.2008.11.027 Bartolomei, 2010, Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course, Int Angiol, 29, 183 Al-Omari, 2010, Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis, Int Angiol, 29, 115 Zivadinov, 2011, Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS, Neurology, 77, 138, 10.1212/WNL.0b013e318212a901 Doepp, 2011, Venous drainage in multiple sclerosis: a combined MRI and ultrasound study, Neurology, 77, 1745, 10.1212/WNL.0b013e318236f0ea Doepp, 2010, No cerebrocervical venous congestion in patients with multiple sclerosis, Ann Neurol, 68, 173 Marder, 2011, No cerebral or cervical venous insufficiency in US veterans with multiple sclerosis, Arch Neurol, 68, 1521, 10.1001/archneurol.2011.185 Centonze, 2011, Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity, Ann Neurol, 70, 51, 10.1002/ana.22436 Sundstrom, 2010, Venous and cerebrospinal fluid flow in multiple sclerosis: a case – control study, Ann Neurol, 68, 255, 10.1002/ana.22132 Wattjes, 2011, No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study, J Neurol Neurosurg Psychiatry, 82, 429, 10.1136/jnnp.2010.223479 Zivadinov, 2011, Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects, Radiology, 258, 562, 10.1148/radiol.10101387 Zamboni, 2009, A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency, J Vasc Surg, 50, 1348, 10.1016/j.jvs.2009.07.096 Bagert, 2011, Chronic cerebrospinal venous insufficiency and multiple sclerosis, Arch Neurol, 68, 1379, 10.1001/archneurol.2011.179 Lassmann, 2005, Multiple sclerosis pathology: evolution of pathogenetic concepts, Brain Pathol, 15, 217, 10.1111/j.1750-3639.2005.tb00523.x Lummel, 2011, Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?, Neuroradiology, 53, 311, 10.1007/s00234-010-0736-z Worthington, 2010, Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency, Neurology, 75, 1617, 10.1212/WNL.0b013e3181fb449e Meyer-Schwickerath, 2011, Intracranial venous pressure is normal in patients with multiple sclerosis, Mult Scler, 17, 637, 10.1177/1352458510395982 Weinstock-Guttman, 2011, Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients, PLoS One, 6, e16802, 10.1371/journal.pone.0016802 Joyner, 2008, A sympathetic view of the sympathetic nervous system and human blood pressure regulation, Exp Physiol, 93, 715, 10.1113/expphysiol.2007.039545 Elenkov, 2000, The sympathetic nerve — an integrative interface between two supersystems: the brain and the immune system, Pharmacol Rev, 52, 595 Sanders, 2002, Norepinephrine, the beta-adrenergic receptor, and immunity, Brain Behav Immun, 16, 290, 10.1006/brbi.2001.0639 Feigl, 1998, Neural control of coronary blood flow, J Vasc Res, 35, 85, 10.1159/000025569 Czura, 2005, Autonomic neural regulation of immunity, J Intern Med, 257, 156, 10.1111/j.1365-2796.2004.01442.x Pavlov, 2004, Neural regulators of innate immune responses and inflammation, Cell Mol Life Sci, 61, 2322, 10.1007/s00018-004-4102-3 Saari, 2010, Sudomotor dysfunction in patients with optic neuritis, Clin Auton Res, 20, 199, 10.1007/s10286-009-0052-z Bradley, 1973, Cystometric and sphincter abnormalities in multiple sclerosis, Neurology, 23, 1131, 10.1212/WNL.23.10.1131 Hinds, 1990, Prevalence of bowel dysfunction in multiple sclerosis. A population survey, Gastroenterology, 98, 1538, 10.1016/0016-5085(90)91087-M Betts, 1993, Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis, J Neurol Neurosurg Psychiatry, 56, 245, 10.1136/jnnp.56.3.245 Sanya, 2005, Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients, Clin Auton Res, 15, 213, 10.1007/s10286-005-0274-7 Lorberboym, 2008, I-123 MIBG cardiac scintigraphy and autonomic test evaluation in multiple sclerosis patients, J Neurol, 255, 211, 10.1007/s00415-008-0652-x Labuz-Roszak, 2007, Difficulties in the diagnosis of autonomic dysfunction in multiple sclerosis, Clin Auton Res, 17, 375, 10.1007/s10286-007-0443-y Flachenecker, 2001, Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability, Mult Scler, 7, 327, 10.1177/135245850100700509 Flachenecker, 2003, Fatigue in MS is related to sympathetic vasomotor dysfunction, Neurology, 61, 851, 10.1212/01.WNL.0000080365.95436.B8 Flachenecker, 1999, Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance, J Neurol, 246, 578, 10.1007/s004150050407 McDougall, 2003, Autonomic nervous system function in multiple sclerosis, J Neurol Sci, 215, 79, 10.1016/S0022-510X(03)00205-3 Gunal, 2002, Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters, Eur Neurol, 48, 1, 10.1159/000064949 Nazliel, 2002, The roles of blink reflex and sympathetic skin response in multiple sclerosis diagnosis, Mult Scler, 8, 500, 10.1191/1352458502ms813oa Vita, 1993, Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions, J Neurol Sci, 120, 82, 10.1016/0022-510X(93)90029-X Kodounis, 2005, Measurement of autonomic dysregulation in multiple sclerosis, Acta Neurol Scand, 112, 403, 10.1111/j.1600-0404.2005.00446.x Leussink, 2003, Autonomic dysregulation in patients with clinically isolated syndrome Surakka, 2008, Pupillary function in early multiple sclerosis, Clin Auton Res, 18, 150, 10.1007/s10286-008-0471-2 Marrosu, 2007, Vagal nerve stimulation improves cerebellar tremor and dysphagia in multiple sclerosis, Mult Scler, 13, 1200, 10.1177/1352458507078399 Khoury, 2010, A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis, Arch Neurol, 67, 1055, 10.1001/archneurol.2010.222 Rajda, 2002, Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients, J Neuroimmunol, 124, 93, 10.1016/S0165-5728(02)00002-4 Karaszewski, 1991, Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28‐suppressor cell, Ann Neurol, 30, 42, 10.1002/ana.410300109 Zoukos, 1992, beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1, Ann Neurol, 31, 657, 10.1002/ana.410310614 Zoukos, 2003, Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study, J Neurol Neurosurg Psychiatry, 74, 197, 10.1136/jnnp.74.2.197 Zoukos, 1994, Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis, Brain, 117, 307, 10.1093/brain/117.2.307 Giorelli, 2004, Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients, J Neuroimmunol, 155, 143, 10.1016/j.jneuroim.2004.05.013 Zeinstra, 2000, [3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain, Neurosci Lett, 289, 75, 10.1016/S0304-3940(00)01254-4 Kooi, 2011, Cholinergic imbalance in the multiple sclerosis hippocampus, Acta Neuropathol, 122, 313, 10.1007/s00401-011-0849-4 Anlar, 1992, Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis, J Neuroimmunol, 36, 171, 10.1016/0165-5728(92)90048-P Iadecola, 2004, Neurovascular regulation in the normal brain and in Alzheimer's disease, Nat Rev Neurosci, 5, 347, 10.1038/nrn1387 Reis, 1997, Autonomic and vasomotor regulation, Int Rev Neurobiol, 41, 121, 10.1016/S0074-7742(08)60350-5 Burton, 1951, On the physical equilibrium of small blood vessels, Am J Physiol, 164, 319, 10.1152/ajplegacy.1951.164.2.319 Panerai, 2003, The critical closing pressure of the cerebral circulation, Med Eng Phys, 25, 621, 10.1016/S1350-4533(03)00027-4 Ursino, 1998, Interaction among autoregulation, CO2 reactivity, and intracranial pressure: a mathematical model, Am J Physiol, 274, H1715 Azevedo, 2011, Autonomic dysfunction affects cerebral neurovascular coupling, Clin Auton Res, 21, 395, 10.1007/s10286-011-0129-3 Sternberg, 2012, The prevalence of cardiovascular risk factors in multiple sclerosis patients Hill, 2007, Cerebral blood flow and intracranial pressure Caicedo, 2011, Impaired cerebral autoregulation using near-infrared spectroscopy and its relation to clinical outcomes in premature infants, Adv Exp Med Biol, 701, 233, 10.1007/978-1-4419-7756-4_31 Chao, 2003, Dynamic cerebrovascular regulation in patients with autonomic dysfunction: a transcranial Doppler study, J Chin Med Assoc, 66, 339 Nasr, 2011, Autonomic neuropathy is associated with impairment of dynamic cerebral autoregulation in type 1 diabetes, Auton Neurosci, 160, 59, 10.1016/j.autneu.2010.10.001 Hollingsworth, 2010, Impaired cerebral autoregulation in primary biliary cirrhosis: implications for the pathogenesis of cognitive decline, Liver Int, 30, 878, 10.1111/j.1478-3231.2010.02259.x Gisolf, 2004, Human cerebral venous outflow pathway depends on posture and central venous pressure, J Physiol, 560, 317, 10.1113/jphysiol.2004.070409 Persson, 1986, Endocrinology of cardiac failure. Pathophysiologic aspects — hemodynamics, Acta Med Scand Suppl, 707, 7 Elsner, 1986, Postsynaptic alpha 1- and alpha 2-adrenergic receptors in adrenergic control of capacitance vessel tone in vivo, Hypertension, 8, 1003, 10.1161/01.HYP.8.11.1003 Auer, 1980, Pial venous constriction during cervical sympathetic stimulation in the cat, Acta Physiol Scand, 110, 203, 10.1111/j.1748-1716.1980.tb06652.x Auer, 1981, Cervical sympathetic nerve stimulation decreases intracranial pressure in the cat, Acta Physiol Scand, 113, 565, 10.1111/j.1748-1716.1981.tb06941.x Wilson, 2005, Reflex-mediated reduction in human cerebral blood volume, J Cereb Blood Flow Metab, 25, 136, 10.1038/sj.jcbfm.9600015 Zhang, 2002, Autonomic neural control of dynamic cerebral autoregulation in humans, Circulation, 106, 1814, 10.1161/01.CIR.0000031798.07790.FE Ogoh, 2008, Autonomic neural control of the cerebral vasculature: acute hypotension, Stroke, 39, 1979, 10.1161/STROKEAHA.107.510008 Markina, 1990, The cholinergic and adrenergic innervation of the great cerebral vein, Fiziol Zh SSSR Im I M Sechenova, 76, 473 Nakakita, 1983, Innervation of the cerebral veins as compared with the cerebral arteries: a histochemical and electron microscopic study, J Cereb Blood Flow Metab, 3, 127, 10.1038/jcbfm.1983.16 Sancesario, 1982, The autonomic innervation of rat jugular vein, Cell Tissue Res, 222, 691, 10.1007/BF00213867 Okamura, 2002, Neurogenic cerebral vasodilation mediated by nitric oxide, Jpn J Pharmacol, 88, 32, 10.1254/jjp.88.32 Glick, 1993, Endothelium-derived nitric oxide reduces baseline venous tone in awake instrumented rats, Am J Physiol, 265, H47 Yuceyar, 2001, Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients, Clin Neurol Neurosurg, 103, 206, 10.1016/S0303-8467(01)00144-5 Aydemir, 2010, Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus, Lupus, 19, 255, 10.1177/0961203309351540 Ananthakrishnan, 2010, Impact of autonomic dysfunction on inflammatory bowel disease, J Clin Gastroenterol, 44, 272, 10.1097/MCG.0b013e3181b2682a Fernandes de Abreu, 2009, Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases, Psychoneuroendocrinology, 34, S265, 10.1016/j.psyneuen.2009.05.023 Gopinath, 2011, Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial, Int J Rheum Dis, 14, 332, 10.1111/j.1756-185X.2011.01684.x Brenner, 1989, In vitro synthesis of antibodies to acetylcholine receptor by Epstein-Barr virus-stimulated B-lymphocytes derived from patients with myasthenia gravis, J Neuroimmunol, 24, 217, 10.1016/0165-5728(89)90119-7 Ebstein, 1985, Beta-adrenergic-stimulated adenylate cyclase activity in normal and EBV-transformed lymphocytes, Experientia, 41, 1552, 10.1007/BF01964803 McKendall, 1990, Unusual manifestations of Epstein-Barr virus encephalomyelitis, Infection, 18, 33, 10.1007/BF01644180 Stumpf, 1987, 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study, Histochemistry, 87, 393, 10.1007/BF00496810 Stumpf, 1988, 1,25(OH)2 vitamin D3 sites of action in spinal cord and sensory ganglion, Anat Embryol (Berl), 177, 307, 10.1007/BF00315837 Santillan, 1999, Activation of a beta-adrenergic-sensitive signal transduction pathway by the secosteroid hormone 1,25-(OH)2-vitamin D3 in chick heart, J Mol Cell Cardiol, 31, 1095, 10.1006/jmcc.1999.0942 Peeyush Kumar, 2011, Expression of cholinergic, insulin, vitamin D receptors and GLUT 3 in the brainstem of streptozotocin induced diabetic rats: effect of treatment with vitamin D, Neurochem Res, 36, 2116, 10.1007/s11064-011-0536-9 Flachenecker, 2007, Autonomic dysfunction in Guillain-Barre syndrome and multiple sclerosis, J Neurol, 254, II96 Sterman, 1985, Disseminated abnormalities of cardiovascular autonomic functions in multiple sclerosis, Neurology, 35, 1665, 10.1212/WNL.35.11.1665 Anema, 1991, Cardiovascular autonomic function in multiple sclerosis, J Neurol Sci, 104, 129, 10.1016/0022-510X(91)90301-M Acevedo, 2000, Cardiovascular dysfunction in multiple sclerosis, Acta Neurol Scand, 101, 85, 10.1034/j.1600-0404.2000.101002085.x Bastianello, 2011, Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study, BMC Neurol, 11, 132, 10.1186/1471-2377-11-132 Flachenecker P., 2009, Cardiovascular autonomic dysfunction in patients with clinically isolated syndrome: a longitudinal study 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) Baracchini, 2011, No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset, Ann Neurol, 69, 90, 10.1002/ana.22228 Nunez-Alvarez, 2011, Pathogenic mechanisms of the anti-phospholipid antibodies, Reumatol Clin, 7, 72 Milovanovic, 2010, Cardiac autonomic dysfunction in patients with systemic lupus, rheumatoid arthritis and sudden death risk, Srp Arh Celok Lek, 138, 26, 10.2298/SARH1002026M Chong, 2003, Hashimoto encephalopathy: syndrome or myth?, Arch Neurol, 60, 164, 10.1001/archneur.60.2.164 Akgul, 2011, Cardiac autonomic function and global left ventricular performance in autoimmune eauthyroid chronic thyroiditis: is treatment necessary at the euthyroid stage?, Echocardiography, 28, 15, 10.1111/j.1540-8175.2010.01240.x Sakakibara, 1996, Micturitional disturbance in acute disseminated encephalomyelitis (ADEM), J Auton Nerv Syst, 60, 200, 10.1016/0165-1838(96)00054-9 Iodice, 2011, Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences, J Neurol Sci, 310, 133, 10.1016/j.jns.2011.07.014 Al-Din, 2005, Trigeminal cephalgias and facial pain syndromes associated with autonomic dysfunction, Cephalalgia, 25, 605, 10.1111/j.1468-2982.2005.00935.x Dionne, 2010, Autonomic nervous symptoms in primary Sjogren's syndrome, Muscle Nerve, 41, 202, 10.1002/mus.21480 Pandit, 2009, Transverse myelitis spectrum disorders, Neurol India, 57, 126, 10.4103/0028-3886.51278 Di Franco, 2009, Autonomic dysfunction and neuropeptide Y in fibromyalgia, Clin Exp Rheumatol, 27, S75 Mandl, 2008, Autonomic nervous symptoms in primary Sjogren's syndrome, Rheumatology (Oxford), 47, 914, 10.1093/rheumatology/ken107 Dolic, 2011, Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers, PLoS One, 6, e28062, 10.1371/journal.pone.0028062 Lampert, 2008, Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men, Am Heart J, 156, 759, 10.1016/j.ahj.2008.07.009 Manfrini, 2008, Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodeling, Atherosclerosis, 197, 183, 10.1016/j.atherosclerosis.2007.03.013 Budeus, 2004, The prediction of atrial fibrillation recurrence after electrical cardioversion with the chemoreflex sensitivity, Z Kardiol, 93, 295, 10.1007/s00392-004-0052-x Alter, 2010, A new method to assess ventricular wall stress in patients with heart failure and its relation to heart rate variability, Int J Cardiol, 139, 301, 10.1016/j.ijcard.2008.09.006 Hypponen, 2008, 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort, Diabetes, 57, 298, 10.2337/db07-1122 Rasic-Milutinovic, 2010, Do components of metabolic syndrome contribute to cardiac autonomic neuropathy in non-diabetic patients?, Saudi Med J, 31, 650 Ehlayel, 2011, Is high prevalence of vitamin D deficiency evidence for asthma and allergy risks?, Eur Ann Allergy Clin Immunol, 43, 81 Lewis, 2006, Autonomic nervous system control of the cardiovascular and respiratory systems in asthma, Respir Med, 100, 1688, 10.1016/j.rmed.2006.01.019 Kubo, 1993, Functional disturbances of the autonomic nerve in nasal hyperreactivity: an up-date review, Acta Otolaryngol Suppl, 500, 97, 10.3109/00016489309126190 Rossato, 2011, Autonomic dysfunction and endothelial changes in migraine sufferers, Panminerva Med, 53, 13 Dobrek, 2006, Autonomic nervous system activity in IBS patients estimated by heart rate variability (HRV), Przegl Lek, 63, 743 Grassi, 1998, Role of the sympathetic nervous system in human hypertension, J Hypertens, 16, 1979, 10.1097/00004872-199816121-00019 Grassi, 1999, How to assess sympathetic activity in humans, J Hypertens, 17, 719, 10.1097/00004872-199917060-00001 Mitchell, 2009, Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans, J Physiol, 587, 2589, 10.1113/jphysiol.2008.167999 Sternberg, 2012, Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy, Curr Pharm Des, 18, 1635, 10.2174/138161212799958639